The tweet was deleted by the author.
But we saved everything 🙂.
CVRx has congratulated Dr. Ryan Burke, Dr. Brian Howard, Dr. Latif Bikak, and the team at Wellstar Kennestone for reaching the milestone of their 50th Barostim implant.
This accomplishment underscores the ongoing commitment to advancing innovative therapy solutions for patients suffering from heart failure. The Barostim device is part of a novel approach designed to improve treatment options and enhance quality of life for those impacted by cardiovascular disease.
CVRx recently hosted a symposium at AAHFN2026 aimed at driving Barostim adoption among advanced practice providers. The company has also commended research teams for their role in advancing clinical trials and patient care, according to a company statement. These initiatives reflect the ongoing focus on expanding treatment options for cardiovascular disease.